Stay updated on GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2. The old revision label was removed and the Back to Top element was dropped; no other core content changes were detected.
    Difference
    0.3%
    Check dated 2025-09-13T17:39:02.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-06T15:18:01.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has been updated to include specific facility names and locations in South Korea, along with a new reference to a clinical trial involving the GX-188 vaccine and pembrolizumab. The revision number has also been updated.
    Difference
    7%
    Check dated 2025-08-30T11:49:25.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:35:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:50:51.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The webpage has been updated with new results and evaluation dates for a clinical study involving tirvalimogene teraplasmid, including specific metrics for efficacy and safety. Additionally, previous results and maintenance alerts have been removed.
    Difference
    7%
    Check dated 2025-08-01T19:22:11.000Z thumbnail image

Stay in the know with updates to GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GX-188E + Pembrolizumab in HPV+ Cervical Cancer Clinical Trial page.